CD52 knockdown inhibits aerobic glycolysis and malignant behavior of NSCLC cells through AKT signaling pathway.
第一作者:
Yini,Cai
第一单位:
Department of Oncology, The Second Affiliated Hospital of Nanchang University; Jiangxi Key Laboratory of Clinical and Translational Cancer Research, 1 Minde Road, Nanchang, Jiangxi, China.
作者:
DOI
10.7150/jca.86511
PMID
38817869
发布时间
2024-06-01
- 浏览0

Journal of Cancer
3394-3405页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文